A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Icahn School Of Medicine At Mount Sinai, New York

Binghamton Gastroenterology Associates, Binghamton

Lehigh Valley Health Network, Allentown

Whitman Walker Health, Washington D.C.

Medstar Washington Hospital Center, Washington D.C.

Capital Medical Associates, Washington D.C.

Johns Hopkins University, Lutherville

Digestive Disease Associates, P.A., Baltimore

Mcguire D V A M C, Richmond

Infect. Disease Specialists, Decatur

Orlando Immunology Center, Orlando

University Of Miami Schiff Center For Liver Diseases, Miami

Midway Immunology And Research Center, Ft. Pierce

University Of Alabama At Birmingham, Birmingham

University Of Cincinnati, Cincinnati

Indiana University Health - University Hospital, Indianapolis

Henry Ford Health System, Detroit

Washington University School Of Medicine, St Louis

Healthcare Research Consultants, Tulsa

Tarrant County Inf Dis Assoc, Fort Worth

Cure C Consortium, Houston

University Of Texas Health Science Center At Houston, Houston

University Of Colorado, Aurora

Clinical Research Centers Of America, Murray

Southwest Care Center, Sante Fe

Peter J Ruane Md Inc, Los Angeles

Anthony M. Mills Md Inc, Los Angeles

Pacific Oaks Medical Group, Beverly Hills

Jeffrey Goodman Special Care Clinic, Los Angeles

Va Long Beach Healthcare System, Long Beach

Ucsd Antiviral Research Center (Avrc), San Diego

Precision Research Institute, Llc, San Diego

University Of California San Francisco, San Francisco

Oregon Health Science Univ, Portland

Harborview Medical Center, Seattle

University Gastroenterology, Providence

The Miriam Hospital, Providence